Compliance & EnforcementCompliance & Enforcement
ArchiveCompliance & Enforcement
14,104 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
U.S. Attorneys’ Offices Adopt Policy Incentivizing Self-Disclosure of Corporate Misconduct
Does “Objective Reasonableness” Matter? Supreme Court Poised to Address Scienter Standard Under the False Claims Act
Upstate New York Nursing Facility Pays Over $7 Million for Allegedly Billing Medicaid for Worthless Services
Analysis of DOJ’s FY 2022 FCA Statistics and the Mixed Signals Therein
Ninth Circuit Revisits Jurisdiction Over FCA Claims Based on Alleged Customs Violations
Corporate Voluntary Self-Disclosure of Criminal Activity: More of the Same or a Real Sea Change?
DOJ Issues Corporate Self-Disclosure Policy
DOJ, Whistleblower Argue that FCA Suit was Not “Commenced by the United States”
Business and Human Rights for Small Companies – What is the Impact of the German Supply Chain Due Diligence Act on the Supplier Side?
DOJ Reaches Settlement with OraPharma, Inc., Pushing Novel AKS Theory
PPP Loan Appeals, SBA Clawbacks and More: What You Need to Know
Second Circuit Rules Anti-Kickback Statute Means No “Corrupt Intent” Required for Liability
Whistleblowers Argue that Seventh Circuit Allows Disingenuous FCA Defense
Fifth Circuit Court of Appeals Reverses Trial Judge’s Dismissal of Criminal FCPA Charges Against Two Venezuelan Officials
Using Data Analytics to Create an Effective Compliance Program
Health Care Enforcement: Review of 2022 and A Look Ahead to 2023
New Voluntary Self-Disclosure Policy for All United States Attorney’s Offices
DOJ’s Near-Record Year of FCA Settlements and Judgments Also Targeted Contractor Cyber-Fraud
Submitting Comments on the Inflation Reduction Act’s Medicare Drug Price Negotiation Program Guidance
Keep reading
